SKI Market

A+| A| A-|

Indian Indices

Sensex

77,470.11 -238.41
( -0.31%)

Global Indices

Nasdaq

52,245.67 385.41
(0.74%)

Dow Jones

7,529.66 65.38
(0.88%)

Hang Seng

66,064.76 1,923.64
(3.00%)

Nikkei 225

10,580.59 55.83
(0.53%)

Forex

USD-INR

96.42 0.06
(0.07%)

EUR-INR

110.27 -0.10
(-0.09%)

GBP-INR

129.65 -0.46
(-0.35%)

JPY-INR

0.59 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

57.69

13900.36

EPS(TTM)

Face Value()

Div & Yield %

23.03

0.57

Back

IndiGrid Infrastructure Trust consolidated net profit rises 76.33% in the December 2025 quarter

Feb 13,2026

Net profit of IndiGrid Infrastructure Trust rose 76.33% to Rs 96.49 crore in the quarter ended December 2025 as against Rs 54.72 crore during the previous quarter ended December 2024. Sales rose 11.66% to Rs 862.24 crore in the quarter ended December 2025 as against Rs 772.22 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	862.24	772.22	12
OPM %	88.45	89.63	-
PBDT	401.67	353.60	14
PBT	109.78	75.01	46
NP	96.49	54.72	76

77,470.11 -238.41 ( -0.31%)

52,245.67 385.41 (0.74%)

7,529.66 65.38 (0.88%)

66,064.76 1,923.64 (3.00%)

10,580.59 55.83 (0.53%)

96.42 0.06 (0.07%)

110.27 -0.10 (-0.09%)

129.65 -0.46 (-0.35%)

0.59 0.00 (-0.05%)